Full Text

Turn on search term navigation

© 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

BACKGROUND

Structural disconnectivity was found to precede dementia. Global white matter abnormalities might also be associated with postoperative delirium (POD).

METHODS

We recruited older patients (≥65 years) without dementia that were scheduled for major surgery. Diffusion kurtosis imaging metrics were obtained preoperatively, after 3 and 12 months postoperatively. We calculated fractional anisotropy (FA), mean diffusivity (MD), mean kurtosis (MK), and free water (FW). A structured and validated delirium assessment was performed twice daily.

RESULTS

Of 325 patients, 53 patients developed POD (16.3%). Preoperative global MD (standardized beta 0.27 [95% confidence interval [CI] 0.21–0.32] p < 0.001) was higher in patients with POD. Preoperative global MK (−0.07 [95% CI −0.11 to (−0.04)] p < 0.001) and FA (0.07 [95% CI −0.10 to (−0.04)] p < 0.001) were lower. When correcting for baseline diffusion, postoperative MD was lower after 3 months (0.05 [95% CI −0.08 to (−0.03)] p < 0.001; n = 183) and higher after 12 months (0.28 [95% CI 0.20–0.35] p < 0.001; n = 45) among patients with POD.

DISCUSSION

Preoperative structural disconnectivity was associated with POD. POD might lead to white matter depletion 3 and 12 months after surgery.

Details

Title
Structural disconnectivity in postoperative delirium: A perioperative two‐center cohort study in older patients
Author
Fislage, Marinus 1   VIAFID ORCID Logo  ; Winzeck, Stefan 2 ; Woodrow, Rebecca 3   VIAFID ORCID Logo  ; Lammers‐Lietz, Florian 4   VIAFID ORCID Logo  ; Stamatakis, Emmanuel A. 3   VIAFID ORCID Logo  ; Correia, Marta M. 5 ; Preller, Jacobus 6   VIAFID ORCID Logo  ; Feinkohl, Insa 7   VIAFID ORCID Logo  ; Hendrikse, Jeroen 8 ; Pischon, Tobias 9   VIAFID ORCID Logo  ; Spies, Claudia D. 4   VIAFID ORCID Logo  ; Slooter, Arjen J. C. 10   VIAFID ORCID Logo  ; Winterer, Georg 11   VIAFID ORCID Logo  ; Menon, David K. 2   VIAFID ORCID Logo  ; Zacharias, Norman 11   VIAFID ORCID Logo 

 Department of Neurology, National Taiwan University Hospital, Taipei City, Taiwan 
 University Division of Anaesthesia, Department of Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK 
 Department of Clinical Neurosciences, University of Cambridge; Addenbrooke's Hospital, Cambridge, UK 
 Department of Anesthesiology and Intensive Care Medicine, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt‐Universität zu Berlin, Berlin, Germany 
 MRC Cognition and Brain Sciences Unit, University of Cambridge, Cambridge, UK 
 Addenbrooke's Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK 
 Max‐Delbrueck‐Center for Molecular Medicine in the Helmholtz Association (MDC), Molecular Epidemiology Research Group, Berlin, Germany 
 Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands 
 Berlin Institute of Health at Charité – Universitätsmedizin Berlin, Core Facility Biobank, Berlin, Germany 
10  Department of Neurology, UZ Brussel and Vrije Universiteit Brussel, Brussels, Belgium 
11  Pharmaimage Biomarker Solutions GmbH, Berlin, Germany 
Pages
2861-2872
Section
RESEARCH ARTICLES
Publication year
2024
Publication date
Apr 1, 2024
Publisher
John Wiley & Sons, Inc.
ISSN
1552-5260
e-ISSN
1552-5279
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3089867572
Copyright
© 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.